Gräs S, Hannibal J, Fahrenkrug J
Department of Clinical Biochemistry, University of Copenhagen, Bispebjerg Hospital, Denmark.
Endocrinology. 1999 May;140(5):2199-205. doi: 10.1210/endo.140.5.6737.
Recently, we have demonstrated that pituitary adenylate cyclase-activating polypeptide (PACAP) is transiently expressed in steroidogenic ovarian cells during the periovulatory period. This prompted us to establish an in vitro system in which the potential local regulatory role of PACAP during periovulatory progesterone production could be examined. Granulosa/lutein cells from PMSG- and human CG (hCG)-stimulated immature rats were used. The cells were isolated from preovulatory follicles 4-6 h after the hCG injection, at which time the transient ovarian PACAP expression begins in vivo. By immunocytochemistry on intact cells and RIA on cell extracts and culture medium, granulosa/lutein cells were found to accumulate and secrete PACAP during incubation. Furthermore, the cells responded to exogenous PACAP 38 with a rapid (10(-7) M induced a peak value 20-fold higher than controls at 2 h) and dose-dependent accumulation of progesterone. PACAP 38 (5 x 10(-9) M), in combination with an approximately half-maximal dose of hCG (1 ng/ml), showed an additive effect on progesterone accumulation. Immunoneutralization of endogenously released PACAP was performed using the IgG fraction from a specific PACAP antiserum that dose-dependently inhibits the progesterone accumulating effect of exogenous PACAP 38. The acute effects of endogenously released PACAP were studied during 8 h of incubation of granulosa/lutein cells with anti-PACAP IgG (100 microg/ml). A significant reduction in progesterone accumulation was observed after 4, 6, and 8 h [38.7% (P < 0.05), 41.2% (P < 0.02), and 50% (P < 0.002), respectively], compared with nonimmune IgG (100 microg/ml) treated cultures. The long-term effects on luteinization induced by endogenously released PACAP were studied after incubation of the cells with anti-PACAP IgG or nonimmune IgG for 24 h, followed by incubation for 9 days in serum-containing medium. Under these conditions, nonimmune IgG-treated cells assumed a luteal phenotype, accumulating large and stable amounts of progesterone and acquiring hypertrophic cell bodies with numerous lipid droplets and distinct nucleoli in the large nuclei. Anti-PACAP IgG-treated cells displayed morphological and functional signs of impaired luteinization being smaller and more irregular and with progesterone accumulation being significantly lower throughout the incubation period [56.4% (P < 0.02), 69.2% (P < 0.05), 43.8% (P < 0.02), and 52.2% (P < 0.02) at 1, 4, 7, and 10 days, respectively]. Together, these findings support an auto- or paracrine role for PACAP during gonadotropin-induced acute periovulatory progesterone production and subsequent luteinization in granulosa/lutein cells.
最近,我们已经证明,垂体腺苷酸环化酶激活多肽(PACAP)在排卵期前后在卵巢类固醇生成细胞中短暂表达。这促使我们建立一个体外系统,在该系统中可以研究PACAP在排卵期孕酮产生过程中潜在的局部调节作用。使用来自促卵泡素(PMSG)和人绒毛膜促性腺激素(hCG)刺激的未成熟大鼠的颗粒/黄体细胞。在注射hCG后4 - 6小时从排卵前卵泡中分离细胞,此时卵巢中PACAP的短暂表达在体内开始。通过对完整细胞进行免疫细胞化学以及对细胞提取物和培养基进行放射免疫分析(RIA),发现颗粒/黄体细胞在孵育过程中积累并分泌PACAP。此外,细胞对外源性PACAP 38有反应,孕酮迅速(10⁻⁷ M在2小时时诱导的峰值比对照高20倍)且呈剂量依赖性积累。PACAP 38(5×10⁻⁹ M)与大约半数最大剂量的hCG(1 ng/ml)联合使用,对孕酮积累显示出相加作用。使用来自特异性PACAP抗血清的IgG组分对内源性释放的PACAP进行免疫中和,该组分剂量依赖性地抑制外源性PACAP 38的孕酮积累作用。在用抗PACAP IgG(100 μg/ml)孵育颗粒/黄体细胞8小时期间研究内源性释放的PACAP的急性作用。与用非免疫IgG(100 μg/ml)处理的培养物相比,在4、6和8小时后观察到孕酮积累显著减少[分别为38.7%(P < 0.05)、41.2%(P < 0.02)和50%(P < 0.002)]。在用抗PACAP IgG或非免疫IgG孵育细胞24小时后,研究内源性释放的PACAP对黄体化的长期作用,随后在含血清的培养基中孵育9天。在这些条件下,用非免疫IgG处理的细胞呈现黄体表型,积累大量且稳定的孕酮,并获得肥大的细胞体,在大细胞核中有许多脂滴和明显的核仁。用抗PACAP IgG处理的细胞在整个孵育期显示出黄体化受损的形态和功能迹象,细胞更小且更不规则,孕酮积累显著更低[在第1、4、7和10天分别为56.4%(P < 0.02)、69.2%(P < 0.05)、43.8%(P < 0.02)和52.2%(P < 0.02)]。总之,这些发现支持PACAP在促性腺激素诱导的急性排卵期孕酮产生以及随后颗粒/黄体细胞黄体化过程中具有自分泌或旁分泌作用。